Peptides for Injury & Recovery

FDA-approved synthetic PTHrP(1-34) analog that stimulates new bone formation and reduces vertebral (86% RRR) and nonvertebral (43% RRR) fracture risk...

FDA-approved synthetic 32-amino-acid polypeptide identical to salmon calcitonin, used for postmenopausal osteoporosis, Paget's disease, and...

FDA-approved GLP-1 receptor agonist for type 2 diabetes, derived from Gila monster venom peptide exendin-4, with consistent evidence for weight...

An FDA-approved long-acting somatostatin analog (brand: Somatuline Depot) indicated for acromegaly, gastroenteropancreatic neuroendocrine tumors...

Liraglutide is an FDA-approved once-daily GLP-1 receptor agonist used for type 2 diabetes (Victoza) and chronic weight management (Saxenda), with...

Teriparatide is an FDA-approved recombinant PTH(1-34) analog that stimulates new bone formation for the treatment of osteoporosis. The pivotal...

A first-in-class dual GIP and GLP-1 receptor agonist approved by the FDA for type 2 diabetes (Mounjaro) and chronic weight management (Zepbound)....

Apraglutide is a novel, long-acting synthetic glucagon-like peptide-2 (GLP-2) analog designed for once-weekly subcutaneous dosing, under clinical...

Investigational once-weekly long-acting amylin receptor agonist developed by Novo Nordisk for obesity and type 2 diabetes. Phase 3 RCTs show...

Investigational once-weekly fixed-dose combination of cagrilintide (amylin analog) and semaglutide (GLP-1 agonist) by Novo Nordisk that achieved...

Cerebrolysin is an injectable porcine brain-derived peptide preparation with neurotrophic, neuroprotective, and neuroplasticity-enhancing properties,...

Retatrutide (LY3437943) is an investigational triple agonist for the GIP, GLP-1, and glucagon receptors developed by Eli Lilly. Phase 2 trials showed...

GHK is a naturally occurring human tripeptide that declines with age, modulates expression of 4,000+ genes toward younger patterns per computational...

GHRP-6 is a synthetic hexapeptide ghrelin mimetic that stimulates pulsatile GH release via the GHS-R1a receptor, with multiple small human endocrine...

Synthetic hexapeptide GH secretagogue that produces rapid, dose-dependent GH release via GHS-R1a activation. The most potent acute GHRP but also...

The only human cathelicidin antimicrobial peptide, a 37-residue cationic alpha-helical peptide cleaved from hCAP18 with broad-spectrum antimicrobial,...

NSI-189 is a novel small molecule neurogenic compound developed for major depressive disorder (MDD) that stimulates hippocampal neurogenesis...

A synthetic 29-amino acid analog of endogenous human GHRH that stimulates pituitary growth hormone release. Previously FDA-approved for pediatric GH...

VIP is a 28-amino acid endogenous neuropeptide and high-affinity agonist at VPAC1 (EC50 0.02-0.03 nM) and VPAC2 (EC50 0.05-0.087 nM) receptors. Acts...

BPC-157 is a synthetic pentadecapeptide derived from human gastric juice protein BPC that demonstrates broad cytoprotective, angiogenic, and...

BPC-157 is a synthetic 15-amino-acid peptide derived from human gastric juice protein BPC that demonstrates broad cytoprotective, pro-angiogenic, and...

A long-acting synthetic analog of growth hormone-releasing hormone (GHRH) that stimulates sustained growth hormone and IGF-1 secretion through a Drug...

A highly selective synthetic pentapeptide agonist of the ghrelin receptor (GHS-R1a) that stimulates robust, pulsatile growth hormone release from the...

Semax is a synthetic heptapeptide analog of ACTH(4-10) developed in Russia, used clinically as an intranasal neuroprotective and nootropic agent...

Thymalin is a polypeptide extract from calf thymus containing short bioactive peptides (EW, KE, EDP) that modulate immune function via...

A synthetic tetrapeptide (Ala-Glu-Asp-Pro) derived from Cortexin brain extract, studied primarily in preclinical models for nerve regeneration,...

A naturally occurring copper-binding tripeptide that modulates the expression of thousands of human genes, promoting tissue repair, collagen/elastin...

A 24-amino acid mitochondrial-derived peptide (MDP) first discovered in 2001 from surviving neurons of Alzheimer's disease brain tissue, with...

A modified IGF-1 analog with reduced IGFBP binding and extended half-life, studied exclusively in animal and in vitro models. Research demonstrates...

C-terminal tripeptide fragment (residues 11-13) of alpha-melanocyte stimulating hormone (alpha-MSH) with potent anti-inflammatory activity mediated...

P21 (P021) is a synthetic tetrapeptide mimetic of ciliary neurotrophic factor (CNTF) designed to promote neurogenesis, enhance BDNF expression, and...

PEG-MGF is a PEGylated form of Mechano Growth Factor (IGF-1Ec), an IGF-1 splice variant produced in muscle after mechanical load. It activates...

A synthetic peptide derived from Thymosin Beta-4 that promotes tissue repair, cell migration, angiogenesis, and anti-inflammatory effects by...